Agilon Health (NYSE:AGL) Stock Price Down 10.1% – Here’s Why

Shares of Agilon Health, Inc. (NYSE:AGL) traded down 10.1% on Thursday . The company traded as low as $95.00 and last traded at $96.15. Approximately 51,126 shares traded hands during trading, a decline of 85% from the average session volume of 349,669 shares. The stock had previously closed at $106.96.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on AGL shares. Robert W. Baird raised their price target on Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Benchmark reissued a “buy” rating and set a $95.00 price objective (up from $13.00) on shares of Agilon Health in a research report on Thursday, May 21st. Wells Fargo & Company restated an “overweight” rating and set a $72.00 price objective (up from $37.50) on shares of Agilon Health in a research note on Friday, May 8th. TD Cowen reaffirmed a “hold” rating and issued a $55.00 target price (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Finally, Citigroup reiterated a “neutral” rating and set a $80.00 price target (up from $18.75) on shares of Agilon Health in a report on Friday, May 15th. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Agilon Health presently has an average rating of “Hold” and a consensus target price of $58.73.

Agilon Health Stock Down 1.6%

The company’s 50 day moving average price is $72.32 and its two-hundred day moving average price is $36.10. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The firm has a market cap of $1.75 billion, a PE ratio of -4.88 and a beta of 3.02.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.76. The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. On average, equities research analysts expect that Agilon Health, Inc. will post -3.5 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Goldman Sachs Group Inc. increased its holdings in shares of Agilon Health by 196.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock worth $13,812,000 after buying an additional 13,283,930 shares during the last quarter. AQR Capital Management LLC lifted its holdings in shares of Agilon Health by 1,346.6% in the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock valued at $7,033,000 after acquiring an additional 9,505,837 shares during the last quarter. North Peak Capital Management LLC grew its position in Agilon Health by 10.8% in the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock worth $26,267,000 after acquiring an additional 3,715,460 shares in the last quarter. Voleon Capital Management LP increased its stake in Agilon Health by 5,519.2% during the third quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock worth $2,823,000 after acquiring an additional 2,692,259 shares during the last quarter. Finally, UBS Group AG increased its stake in Agilon Health by 250.7% during the fourth quarter. UBS Group AG now owns 3,395,366 shares of the company’s stock worth $2,339,000 after acquiring an additional 2,427,136 shares during the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.